- Home
- NERV vs LFWD Comparison
NERV vs LFWD Comparison
Compare NERV & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- LFWD
- Stock Information
- Founded
- NERV 2007
- LFWD 2001
- Country
- NERV United States
- LFWD Israel
- Employees
- NERV N/A
- LFWD N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- LFWD
- Sector
- NERV Health Care
- LFWD
- Exchange
- NERV Nasdaq
- LFWD NYSE
- Market Cap
- NERV 12.6M
- LFWD 11.8M
- IPO Year
- NERV 2014
- LFWD 2014
- Fundamental
- Price
- NERV $1.73
- LFWD $0.67
- Analyst Decision
- NERV Hold
- LFWD Strong Buy
- Analyst Count
- NERV 1
- LFWD 3
- Target Price
- NERV $5.00
- LFWD $9.00
- AVG Volume (30 Days)
- NERV 12.1K
- LFWD 1.4M
- Earning Date
- NERV 08-05-2025
- LFWD 08-14-2025
- Dividend Yield
- NERV N/A
- LFWD N/A
- EPS Growth
- NERV N/A
- LFWD N/A
- EPS
- NERV 0.83
- LFWD N/A
- Revenue
- NERV N/A
- LFWD $25,414,000.00
- Revenue This Year
- NERV N/A
- LFWD $12.04
- Revenue Next Year
- NERV N/A
- LFWD $40.58
- P/E Ratio
- NERV $2.06
- LFWD N/A
- Revenue Growth
- NERV N/A
- LFWD 41.92
- 52 Week Low
- NERV $1.15
- LFWD $0.50
- 52 Week High
- NERV $3.50
- LFWD $4.77
- Technical
- Relative Strength Index (RSI)
- NERV 50.22
- LFWD 26.29
- Support Level
- NERV $1.57
- LFWD $0.55
- Resistance Level
- NERV $1.88
- LFWD $0.73
- Average True Range (ATR)
- NERV 0.09
- LFWD 0.10
- MACD
- NERV -0.02
- LFWD -0.03
- Stochastic Oscillator
- NERV 52.03
- LFWD 23.23
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.